Logo image of MYND

MYND.AI INC (MYND) Stock Fundamental Analysis

NYSEARCA:MYND - US6289881079 - ADR

0.5801 USD
-0.02 (-3.33%)
Last: 8/25/2025, 8:04:02 PM
0.585 USD
+0 (+0.84%)
After Hours: 8/25/2025, 8:04:02 PM
Fundamental Rating

1

Taking everything into account, MYND scores 1 out of 10 in our fundamental rating. MYND was compared to 71 industry peers in the Diversified Consumer Services industry. MYND has a bad profitability rating. Also its financial health evaluation is rather negative. MYND does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year MYND has reported negative net income.
In the past year MYND had a positive cash flow from operations.
MYND had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MYND reported negative operating cash flow in multiple years.
MYND Yearly Net Income VS EBIT VS OCF VS FCFMYND Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -37.89%, MYND is doing worse than 80.28% of the companies in the same industry.
The Return On Equity of MYND (-337.45%) is worse than 80.28% of its industry peers.
Industry RankSector Rank
ROA -37.89%
ROE -337.45%
ROIC N/A
ROA(3y)-32.96%
ROA(5y)-21.76%
ROE(3y)-180.35%
ROE(5y)-118.21%
ROIC(3y)N/A
ROIC(5y)N/A
MYND Yearly ROA, ROE, ROICMYND Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

With a Gross Margin value of 24.77%, MYND is not doing good in the industry: 73.24% of the companies in the same industry are doing better.
MYND's Gross Margin has improved in the last couple of years.
MYND does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y72.61%
GM growth 5Y11.08%
MYND Yearly Profit, Operating, Gross MarginsMYND Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1

2. Health

2.1 Basic Checks

MYND does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MYND has been reduced compared to 1 year ago.
The number of shares outstanding for MYND has been increased compared to 5 years ago.
The debt/assets ratio for MYND is higher compared to a year ago.
MYND Yearly Shares OutstandingMYND Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MYND Yearly Total Debt VS Total AssetsMYND Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -1.76, we must say that MYND is in the distress zone and has some risk of bankruptcy.
MYND has a Altman-Z score of -1.76. This is in the lower half of the industry: MYND underperforms 74.65% of its industry peers.
MYND has a Debt/Equity ratio of 2.22. This is a high value indicating a heavy dependency on external financing.
MYND has a worse Debt to Equity ratio (2.22) than 76.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.22
Debt/FCF N/A
Altman-Z -1.76
ROIC/WACCN/A
WACC7.4%
MYND Yearly LT Debt VS Equity VS FCFMYND Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

MYND has a Current Ratio of 1.13. This is a normal value and indicates that MYND is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.13, MYND is in line with its industry, outperforming 46.48% of the companies in the same industry.
MYND has a Quick Ratio of 1.13. This is a bad value and indicates that MYND is not financially healthy enough and could expect problems in meeting its short term obligations.
MYND has a Quick ratio of 0.91. This is comparable to the rest of the industry: MYND outperforms 40.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.91
MYND Yearly Current Assets VS Current LiabilitesMYND Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1

3. Growth

3.1 Past

MYND shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -152.26%.
MYND shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.06%.
MYND shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.96% yearly.
EPS 1Y (TTM)-152.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-152.26%
Revenue 1Y (TTM)-35.06%
Revenue growth 3Y72.71%
Revenue growth 5Y7.96%
Sales Q2Q%-35.06%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MYND Yearly Revenue VS EstimatesMYND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
MYND Yearly EPS VS EstimatesMYND Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 0 -10 -20

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYND. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYND Price Earnings VS Forward Price EarningsMYND Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYND Per share dataMYND EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MYND!.
Industry RankSector Rank
Dividend Yield N/A

MYND.AI INC

NYSEARCA:MYND (8/25/2025, 8:04:02 PM)

After market: 0.585 +0 (+0.84%)

0.5801

-0.02 (-3.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)03-25 2025-03-25
Earnings (Next)08-27 2025-08-27
Inst Owners0.44%
Inst Owner Change-18.18%
Ins OwnersN/A
Ins Owner Change0%
Market Cap26.39M
Analysts40
Price TargetN/A
Short Float %0.02%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF N/A
P/OCF 33.58
P/B 0.93
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.3
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0.02
OCFY2.98%
SpS5.88
BVpS0.62
TBVpS-1.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.89%
ROE -337.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.77%
FCFM N/A
ROA(3y)-32.96%
ROA(5y)-21.76%
ROE(3y)-180.35%
ROE(5y)-118.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y72.61%
GM growth 5Y11.08%
F-Score5
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 2.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 171.08%
Cap/Sales 3.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.91
Altman-Z -1.76
F-Score5
WACC7.4%
ROIC/WACCN/A
Cap/Depr(3y)112.58%
Cap/Depr(5y)85.13%
Cap/Sales(3y)4.32%
Cap/Sales(5y)7.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-152.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-152.26%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.06%
Revenue growth 3Y72.71%
Revenue growth 5Y7.96%
Sales Q2Q%-35.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-108.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y133.33%
OCF growth 3Y-65.55%
OCF growth 5Y-42.93%